CEDIA Cyclosporine-PLUS Assay

GUDID 00884883011861

Microgenics Corporation

Cyclosporin A/cyclosporine therapeutic drug monitoring IVD, kit, fluorescent immunoassay

• Primary Device ID: 00884883011861
• NIH Device Record Key: a7657009-1dd8-405c-abe4-fe7e443d1fa2
• Commercial Distribution Status: In Commercial Distribution
• Brand Name: CEDIA Cyclosporine-PLUS Assay
• Version Model Number: 10016283
• Company DUNS: 122153799
• Company Name: Microgenics Corporation
• Device Count: 1
• DM Exempt: false
• Pre-market Exempt: false
• MRI Safety Status: Labeling does not contain MRI Safety Information
• Human Cell/Tissue Product: false
• Device Kit: false
• Device Combination Product: false
• Single Use: true
• Lot Batch: true
• Serial Number: false
• Manufacturing Date: false
• Expiration Date: true
• Donation Id Number: false
• Contains Natural Rubber Latex: false
• Labeled No Natural Rubber Latex: false
• RX Perscription: false
• OTC Over-The-Counter: false

Device Identifiers

Device Issuing Agency	Device ID
GS1	00884883011861 [Primary]

FDA Pre-market Approvals/Notifications & deNovo

• Premarket Notification: K023208

FDA Product Code

• JIS: Calibrator, Primary
• MKW: Cyclosporine

Sterilization

• Steralize Prior To Use: false
• Device Is Sterile: false

Device Entry Metadata

• Public Version Status: Update
• Device Record Status: Published
• Public Version Number: 4
• Public Version Date: 2019-04-30
• Device Publish Date: 2016-09-24

Devices Manufactured by Microgenics Corporation

• 00884883008830 - MAS Diabetes Max-SP (Sample-Pack): 2024-05-29
• 00884883008823 - MAS Diabetes Max, Multi-pack: 2024-05-28
• 00884883006027 - Acrometrix BB NAT HBV Positive Control: 2022-10-17
• 00884883007376 - MAS omni Infectious BSI Positive Control Panel for use with Siemens Assays: 2021-11-11
• 07613336190791 - OXY DRI Oxycodone: 2021-11-03
• 00884883007383 - MAS anti-HBs Positive Control – For use with Siemens Assays: 2021-05-13
• 00884883007765 - MAS SARS-CoV-2 IgG Positive Control: 2021-03-15
• 00884883007772 - MAS SARS-CoV-2 Negative Control: 2021-03-15